Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

@article{Coelho2010PregnancyOI,
  title={Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study},
  author={J. Coelho and L. Beaugerie and J. Colombel and X. H{\'e}buterne and {\'E}. Lerebours and M. L{\'e}mann and P. Baumer and J. Cosnes and A. Bourreille and J. Gendre and P. Seksik and A. Blain and E. Metman and A. Nisard and G. Cadiot and M. Veyrac and B. Coffin and X. Dray and F. Carrat and P. Marteau},
  journal={Gut},
  year={2010},
  volume={60},
  pages={198 - 203}
}
Background and aims Few studies have been conducted addressing the safety of thiopurine treatment in pregnant women with inflammatory bowel disease (IBD). The aim of this study was to evaluate the pregnancy outcome of women with IBD who have been exposed to thiopurines. Methods 215 pregnancies in 204 women were registered and documented in the CESAME cohort between May 2004 and October 2007. Physicians documented the following information from the women: last menstrual date, delivery term… Expand
145 Citations
The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy
Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 36 REFERENCES
[Pregnancy outcome in inflammatory bowel diseases].
Early pregnancy azathioprine use and pregnancy outcomes.
...
1
2
3
4
...